In our last episode of season one, we hear from a few more listeners and have a meta-conversation about the podcast itself. Vanessa and Casper also have the opportunity to chat with Professor Stephanie Paulsell, with whom they developed this project at Harvard Divinity School. We’re back with season two in a few weeks! Note: This is our last week of particularly bad audio quality. Hurray!
Charley Grant joins Miriam Gottfried and Ken Brown to talk about the public scrutiny Mylan is facing over its pricing of EpiPen--and how a tweet from Hillary Clinton sent things into overdrive. Then, Anjani Trivedi joins the show to discuss why investors are turning to risky emerging-market bonds in the global quest for yield.
What's up with the explosion of borrowed money in America?